Every NSE & BSE company
5,563 listed companies, ranked by market cap. Open any company to see every announcement it has filed: order wins, results, earnings calls, fund raises, board meetings and more.
Sector
All sectors
Banking and Finance 625Commercial Services & Supplies 576General Industrials 480Textiles Apparels & Accessories 455Software & Services 312Chemicals & Petrochemicals 258Metals & Mining 257Cement and Construction 254Pharmaceuticals & Biotechnology 231Food, Beverages & Tobacco 229Automobiles & Auto Components 214Realty 210Consumer Durables 183FMCG 138Transportation 136Diversified Consumer Services 122Utilities 115Media 107Healthcare 99Retailing 91Hotels Restaurants & Tourism 85Oil & Gas 43Others 34Fertilizers 30Hardware Technology & Equipment 28Diversified 26Telecommunications Equipment 21Forest Materials 20Telecom Services 19
| # | Company | Sector | Market cap | Announcements | Latest |
|---|---|---|---|---|---|
| 11 | Sun Pharmaceutical Industries LtdNSE: SUNPHARMA · BSE: 524715 | Pharmaceuticals & Biotechnology | ₹4,44,405 Cr | 16 | Promoter Reclassification26 Sep 2026 |
| 35 | Divi's Laboratories LtdNSE: DIVISLAB · BSE: 532488 | Pharmaceuticals & Biotechnology | ₹2,55,368 Cr | 9 | Other Announcement26 Sep 2026 |
| 49 | Torrent Pharmaceuticals LtdNSE: TORNTPHARM · BSE: 500420 | Pharmaceuticals & Biotechnology | ₹1,89,747 Cr | 6 | Annual General Meeting7 Sep 2026 |
| 83 | Zydus Lifesciences LtdNSE: ZYDUSLIFE · BSE: 532321 | Pharmaceuticals & Biotechnology | ₹1,21,141 Cr | 10 | Business Update26 Sep 2026 |
| 97 | Cipla LtdNSE: CIPLA · BSE: 500087 | Pharmaceuticals & Biotechnology | ₹1,13,076 Cr | 9 | Employee Stock Options24 Sep 2026 |
| 101 | Laurus Labs LtdNSE: LAURUSLABS · BSE: 540222 | Pharmaceuticals & Biotechnology | ₹1,08,441 Cr | 8 | Earnings Call18 Sep 2026 |
| 114 | Mankind Pharma LtdNSE: MANKIND · BSE: 543904 | Pharmaceuticals & Biotechnology | ₹1,02,225 Cr | 9 | Annual General Meeting17 Sep 2026 |
| 117 | Dr. Reddy's Laboratories LtdNSE: DRREDDY · BSE: 500124 | Pharmaceuticals & Biotechnology | ₹1,00,245 Cr | 10 | Board Meeting Date22 Sep 2026 |
| 118 | Aurobindo Pharma LtdNSE: AUROPHARMA · BSE: 524804 | Pharmaceuticals & Biotechnology | ₹99,433 Cr | 10 | Regulatory Approval15 Sep 2026 |
| 124 | Lupin LtdNSE: LUPIN · BSE: 500257 | Pharmaceuticals & Biotechnology | ₹95,665 Cr | 10 | Employee Stock Options21 Sep 2026 |
| 169 | Glenmark Pharmaceuticals LtdNSE: GLENMARK · BSE: 532296 | Pharmaceuticals & Biotechnology | ₹67,169 Cr | 13 | Business Update23 Sep 2026 |
| 178 | Alkem Laboratories LtdNSE: ALKEM · BSE: 539523 | Pharmaceuticals & Biotechnology | ₹63,059 Cr | 10 | Management Change24 Sep 2026 |
| 181 | Biocon LtdNSE: BIOCON · BSE: 532523 | Pharmaceuticals & Biotechnology | ₹62,279 Cr | 10 | Business Update21 Sep 2026 |
| 192 | Abbott India LtdNSE: ABBOTINDIA · BSE: 500488 | Pharmaceuticals & Biotechnology | ₹57,277 Cr | 3 | Management Change7 Sep 2026 |
| 207 | Ipca Laboratories LtdNSE: IPCALAB · BSE: 524494 | Pharmaceuticals & Biotechnology | ₹50,000 Cr | 4 | Earnings Call17 Aug 2026 |
| 208 | Anthem Biosciences LtdNSE: ANTHEM · BSE: 544449 | Pharmaceuticals & Biotechnology | ₹49,201 Cr | 10 | Other Announcement21 Sep 2026 |
| 212 | Gland Pharma LtdNSE: GLAND · BSE: 543245 | Pharmaceuticals & Biotechnology | ₹48,137 Cr | 13 | Merger & Restructuring13 Sep 2026 |
| 215 | GlaxoSmithKline Pharmaceuticals LtdNSE: GLAXO · BSE: 500660 | Pharmaceuticals & Biotechnology | ₹47,700 Cr | 9 | Annual General Meeting15 Sep 2026 |
| 223 | Ajanta Pharma LtdNSE: AJANTPHARM · BSE: 532331 | Pharmaceuticals & Biotechnology | ₹44,333 Cr | 6 | Share Pledge18 Sep 2026 |
| 249 | Emcure Pharmaceuticals LtdNSE: EMCURE · BSE: 544210 | Pharmaceuticals & Biotechnology | ₹37,005 Cr | 10 | Earnings Call25 Sep 2026 |
| 251 | Wockhardt LtdNSE: WOCKPHARMA · BSE: 532300 | Pharmaceuticals & Biotechnology | ₹36,814 Cr | 4 | Financial Results10 Aug 2026 |
| 264 | Sai Life Science LtdNSE: SAILIFE · BSE: 544306 | Pharmaceuticals & Biotechnology | ₹33,821 Cr | 8 | Employee Stock Options18 Sep 2026 |
| 308 | Neuland Laboratories LtdNSE: NEULANDLAB · BSE: 524558 | Pharmaceuticals & Biotechnology | ₹28,085 Cr | 9 | Production Started15 Sep 2026 |
| 310 | Piramal Pharma LtdNSE: PPLPHARMA · BSE: 543635 | Pharmaceuticals & Biotechnology | ₹28,000 Cr | 6 | Other Announcement18 Sep 2026 |
| 311 | Rubicon Research LtdNSE: RUBICON · BSE: 544578 | Pharmaceuticals & Biotechnology | ₹27,748 Cr | 10 | Capital Structure Change16 Sep 2026 |
| 314 | Acutaas Chemicals LtdNSE: ACUTAAS · BSE: 543349 | Pharmaceuticals & Biotechnology | ₹26,792 Cr | 14 | Management Change26 Sep 2026 |
| 366 | Caplin Point Laboratories LtdNSE: CAPLIPOINT · BSE: 524742 | Pharmaceuticals & Biotechnology | ₹21,550 Cr | 12 | Annual General Meeting25 Sep 2026 |
| 367 | Granules India LtdNSE: GRANULES · BSE: 532482 | Pharmaceuticals & Biotechnology | ₹21,525 Cr | 17 | Promoter Buying25 Sep 2026 |
| 388 | Shilpa Medicare LtdNSE: SHILPAMED · BSE: 530549 | Pharmaceuticals & Biotechnology | ₹19,821 Cr | 14 | Share Pledge26 Sep 2026 |
| 400 | OneSource Specialty Pharma LtdNSE: ONESOURCE · BSE: 544292 | Pharmaceuticals & Biotechnology | ₹18,377 Cr | 12 | Employee Stock Options25 Sep 2026 |
| 402 | Pfizer LtdNSE: PFIZER · BSE: 500680 | Pharmaceuticals & Biotechnology | ₹18,303 Cr | 4 | Management Change18 Sep 2026 |
| 415 | Cohance Lifesciences LtdNSE: COHANCE · BSE: 543064 | Pharmaceuticals & Biotechnology | ₹17,571 Cr | 10 | Business Update21 Sep 2026 |
| 417 | Eris Lifesciences LtdNSE: ERIS · BSE: 540596 | Pharmaceuticals & Biotechnology | ₹17,466 Cr | 17 | Annual General Meeting25 Sep 2026 |
| 422 | Jubilant Pharmova LtdNSE: JUBLPHARMA · BSE: 530019 | Pharmaceuticals & Biotechnology | ₹17,074 Cr | 4 | Business Update11 Sep 2026 |
| 424 | Alembic Pharmaceuticals LtdNSE: APLLTD · BSE: 533573 | Pharmaceuticals & Biotechnology | ₹16,978 Cr | 14 | Debt & Borrowing25 Sep 2026 |
| 426 | Alivus Life Sciences LtdNSE: ALIVUS · BSE: 543322 | Pharmaceuticals & Biotechnology | ₹16,766 Cr | 9 | Merger & Restructuring16 Sep 2026 |
| 439 | AstraZeneca Pharma India LtdNSE: ASTRAZEN · BSE: 506820 | Pharmaceuticals & Biotechnology | ₹16,262 Cr | 6 | Legal & Regulatory18 Sep 2026 |
| 464 | Syngene International LtdNSE: SYNGENE · BSE: 539268 | Pharmaceuticals & Biotechnology | ₹15,287 Cr | 9 | Management Change21 Sep 2026 |
| 465 | Marksans Pharma LtdNSE: MARKSANS · BSE: 524404 | Pharmaceuticals & Biotechnology | ₹15,269 Cr | 10 | Promoter Selling (Off-Market)18 Sep 2026 |
| 467 | Concord Biotech LtdNSE: CONCORDBIO · BSE: 543960 | Pharmaceuticals & Biotechnology | ₹15,207 Cr | 11 | Bonus Issue23 Sep 2026 |
| 472 | Natco Pharma LtdNSE: NATCOPHARM · BSE: 524816 | Pharmaceuticals & Biotechnology | ₹15,033 Cr | 18 | Fund Raise25 Sep 2026 |
| 521 | Sudeep Pharma LtdNSE: SUDEEPPHRM · BSE: 544619 | Pharmaceuticals & Biotechnology | ₹13,157 Cr | 8 | Other Announcement22 Sep 2026 |
| 527 | Corona Remedies LtdNSE: CORONA · BSE: 544644 | Pharmaceuticals & Biotechnology | ₹12,952 Cr | 8 | Capital Structure Change19 Sep 2026 |
| 531 | Akums Drugs & Pharmaceuticals LtdNSE: AKUMS · BSE: 544222 | Pharmaceuticals & Biotechnology | ₹12,899 Cr | 8 | Other Announcement3 Sep 2026 |
| 577 | Strides Pharma Science LtdNSE: STAR · BSE: 532531 | Pharmaceuticals & Biotechnology | ₹10,922 Cr | 7 | Business Update11 Sep 2026 |
| 582 | Viyash Scientific LtdNSE: VIYASH · BSE: 512529 | Pharmaceuticals & Biotechnology | ₹10,791 Cr | 13 | Employee Stock Options18 Sep 2026 |
| 602 | Blue Jet Healthcare LtdNSE: BLUEJET · BSE: 544009 | Pharmaceuticals & Biotechnology | ₹9,899 Cr | 8 | Annual General Meeting21 Sep 2026 |
| 632 | Sanofi Consumer Healthcare India LtdNSE: SANOFICONR · BSE: 544250 | Pharmaceuticals & Biotechnology | ₹9,086 Cr | 2 | Financial Results28 Jul 2026 |
| 638 | Procter & Gamble Health LtdNSE: PGHL · BSE: 500126 | Pharmaceuticals & Biotechnology | ₹8,974 Cr | 5 | Other Announcement18 Sep 2026 |
| 654 | Aarti Pharmalabs LtdNSE: AARTIPHARM · BSE: 543748 | Pharmaceuticals & Biotechnology | ₹8,520 Cr | 13 | Promoter Selling25 Sep 2026 |
| 679 | Supriya Lifescience LtdNSE: SUPRIYA · BSE: 543434 | Pharmaceuticals & Biotechnology | ₹7,929 Cr | 12 | Annual General Meeting25 Sep 2026 |
| 705 | Bliss GVS Pharma LtdNSE: BLISSGVS · BSE: 506197 | Pharmaceuticals & Biotechnology | ₹7,493 Cr | 6 | Annual General Meeting22 Sep 2026 |
| 718 | Innova Captab LtdNSE: INNOVACAP · BSE: 544067 | Pharmaceuticals & Biotechnology | ₹7,331 Cr | 11 | Other Announcement4 Sep 2026 |
| 720 | Sanofi India LtdNSE: SANOFI · BSE: 500674 | Pharmaceuticals & Biotechnology | ₹7,232 Cr | 11 | Legal & Regulatory25 Sep 2026 |
| 750 | Sun Pharma Advanced Research Company LtdNSE: SPARC · BSE: 532872 | Pharmaceuticals & Biotechnology | ₹6,784 Cr | 2 | Financial Results10 Aug 2026 |
| 767 | Morepen Laboratories LtdNSE: MOREPENLAB · BSE: 500288 | Pharmaceuticals & Biotechnology | ₹6,596 Cr | 10 | Annual General Meeting26 Sep 2026 |
| 775 | Symbiotec Pharmalab LtdNSE: SYMBIOTEC · BSE: 544889 | Pharmaceuticals & Biotechnology | ₹6,447 Cr | 7 | Earnings Call22 Sep 2026 |
| 779 | Orchid Pharma LtdNSE: ORCHPHARMA · BSE: 524372 | Pharmaceuticals & Biotechnology | ₹6,377 Cr | 15 | Capital Structure Change23 Sep 2026 |
| 781 | Jeena Sikho Lifecare LtdNSE: JSLL · BSE: 544476 | Pharmaceuticals & Biotechnology | ₹6,318 Cr | 15 | Employee Stock Options23 Sep 2026 |
| 786 | Senores Pharmaceuticals LtdNSE: SENORES · BSE: 544319 | Pharmaceuticals & Biotechnology | ₹6,241 Cr | 13 | Annual General Meeting25 Sep 2026 |
| 799 | IOL Chemicals and Pharmaceuticals LtdNSE: IOLCP · BSE: 524164 | Pharmaceuticals & Biotechnology | ₹5,994 Cr | 12 | Regulatory Approval23 Sep 2026 |
| 826 | FDC LtdNSE: FDC · BSE: 531599 | Pharmaceuticals & Biotechnology | ₹5,552 Cr | 4 | Annual General Meeting17 Sep 2026 |
| 837 | Gujarat Themis Biosyn LtdNSE: GUJTHEM · BSE: 506879 | Pharmaceuticals & Biotechnology | ₹5,427 Cr | 18 | Annual General Meeting21 Sep 2026 |
| 867 | RPG Life Sciences LtdNSE: RPGLIFE · BSE: 532983 | Pharmaceuticals & Biotechnology | ₹5,045 Cr | 13 | Merger & Restructuring26 Sep 2026 |
| 888 | Novartis India LtdNSE: NOVARTIND · BSE: 500672 | Pharmaceuticals & Biotechnology | ₹4,843 Cr | 10 | Annual General Meeting18 Sep 2026 |
| 909 | Zota Healthcare LtdNSE: ZOTA | Pharmaceuticals & Biotechnology | ₹4,629 Cr | 11 | Annual General Meeting21 Sep 2026 |
| 936 | Gufic BioSciences LtdNSE: GUFICBIO · BSE: 509079 | Pharmaceuticals & Biotechnology | ₹4,249 Cr | 11 | Legal & Regulatory24 Sep 2026 |
| 940 | SMS Pharmaceuticals LtdNSE: SMSPHARMA · BSE: 532815 | Pharmaceuticals & Biotechnology | ₹4,211 Cr | 9 | Other Announcement21 Sep 2026 |
| 969 | Aarti Drugs LtdNSE: AARTIDRUGS · BSE: 524348 | Pharmaceuticals & Biotechnology | ₹3,901 Cr | 12 | Management Change26 Sep 2026 |
| 971 | Unichem Laboratories LtdNSE: UNICHEMLAB · BSE: 506690 | Pharmaceuticals & Biotechnology | ₹3,870 Cr | 5 | Business Update26 Sep 2026 |
| 981 | Kwality Pharmaceuticals LtdNSE: KPL · BSE: 539997 | Pharmaceuticals & Biotechnology | ₹3,810 Cr | 7 | Management Change2 Sep 2026 |
| 1007 | Solara Active Pharma Sciences LtdNSE: SOLARA · BSE: 541540 | Pharmaceuticals & Biotechnology | ₹3,552 Cr | 7 | Other Announcement26 Sep 2026 |
| 1013 | Ind-Swift Laboratories LtdNSE: INDSWFTLAB · BSE: 532305 | Pharmaceuticals & Biotechnology | ₹3,516 Cr | 12 | Other Announcement25 Sep 2026 |
| 1039 | Advanced Enzyme Technologies LtdNSE: ADVENZYMES · BSE: 540025 | Pharmaceuticals & Biotechnology | ₹3,260 Cr | 25 | Capital Structure Change25 Sep 2026 |
| 1120 | Alembic LtdNSE: ALEMBICLTD · BSE: 506235 | Pharmaceuticals & Biotechnology | ₹2,736 Cr | 7 | Promoter Buying25 Sep 2026 |
| 1127 | Hikal LtdNSE: HIKAL · BSE: 524735 | Pharmaceuticals & Biotechnology | ₹2,683 Cr | 9 | Annual General Meeting23 Sep 2026 |
| 1135 | Dishman Carbogen Amcis LtdNSE: DCAL · BSE: 540701 | Pharmaceuticals & Biotechnology | ₹2,637 Cr | 11 | Debt & Borrowing25 Sep 2026 |
| 1154 | Sakar Healthcare LtdNSE: SAKAR | Pharmaceuticals & Biotechnology | ₹2,527 Cr | 8 | Other Announcement22 Sep 2026 |
| 1166 | Shukra Pharmaceuticals LtdNSE: SHUKRAPHAR · BSE: 524632 | Pharmaceuticals & Biotechnology | ₹2,456 Cr | 7 | Annual General Meeting22 Sep 2026 |
| 1190 | Indoco Remedies LtdNSE: INDOCO · BSE: 532612 | Pharmaceuticals & Biotechnology | ₹2,349 Cr | 11 | Other Announcement24 Sep 2026 |
| 1196 | Beta Drugs LtdNSE: BETA · BSE: 531481 | Pharmaceuticals & Biotechnology | ₹2,327 Cr | 8 | Business Update22 Sep 2026 |
| 1198 | Windlas Biotech LtdNSE: WINDLAS · BSE: 543329 | Pharmaceuticals & Biotechnology | ₹2,314 Cr | 6 | Earnings Call14 Aug 2026 |
| 1202 | Panacea Biotec LtdNSE: PANACEABIO · BSE: 531349 | Pharmaceuticals & Biotechnology | ₹2,282 Cr | 6 | Legal & Regulatory26 Sep 2026 |
| 1215 | Venus Remedies LtdNSE: VENUSREM · BSE: 526953 | Pharmaceuticals & Biotechnology | ₹2,230 Cr | 3 | Other Announcement7 Sep 2026 |
| 1219 | Sai Parenterals LtdNSE: SAIPARENT · BSE: 544742 | Pharmaceuticals & Biotechnology | ₹2,226 Cr | 7 | Annual General Meeting10 Sep 2026 |
| 1281 | Fredun Pharmaceuticals LtdNSE: FREDUN · BSE: 539730 | Pharmaceuticals & Biotechnology | ₹1,944 Cr | 11 | Capital Structure Change22 Sep 2026 |
| 1292 | Syncom Formulation (India) LtdNSE: SYNCOMF · BSE: 524470 | Pharmaceuticals & Biotechnology | ₹1,885 Cr | 7 | Other Announcement26 Sep 2026 |
| 1298 | Hester Biosciences LtdNSE: HESTERBIO · BSE: 524669 | Pharmaceuticals & Biotechnology | ₹1,857 Cr | 8 | Promoter Reclassification4 Sep 2026 |
| 1313 | NGL Fine - Chem LtdNSE: NGLFINE · BSE: 524774 | Pharmaceuticals & Biotechnology | ₹1,795 Cr | 8 | Legal & Regulatory25 Sep 2026 |
| 1370 | Accent Microcell LtdNSE: ACCENTMIC | Pharmaceuticals & Biotechnology | ₹1,619 Cr | 4 | Earnings Call21 May 2026 |
| 1377 | Jagsonpal Pharmaceuticals LtdNSE: JAGSNPHARM · BSE: 507789 | Pharmaceuticals & Biotechnology | ₹1,598 Cr | 8 | Acquisition23 Sep 2026 |
| 1421 | Amrutanjan Health Care LtdNSE: AMRUTANJAN · BSE: 590006 | Pharmaceuticals & Biotechnology | ₹1,464 Cr | 6 | Annual General Meeting23 Sep 2026 |
| 1450 | Fermenta Biotech LtdNSE: FERMENTA · BSE: 506414 | Pharmaceuticals & Biotechnology | ₹1,378 Cr | 7 | Other Announcement10 Sep 2026 |
| 1451 | Kopran LtdNSE: KOPRAN · BSE: 524280 | Pharmaceuticals & Biotechnology | ₹1,375 Cr | 7 | Price Movement Clarification22 Sep 2026 |
| 1466 | Vikram Thermo (India) LtdNSE: VIKRAMTH · BSE: 530477 | Pharmaceuticals & Biotechnology | ₹1,341 Cr | 5 | Dividend4 Sep 2026 |
| 1482 | Bharat Parenterals LtdNSE: BPLPHARMA · BSE: 541096 | Pharmaceuticals & Biotechnology | ₹1,306 Cr | 9 | Board Meeting Date24 Sep 2026 |
| 1522 | Lincoln Pharmaceuticals LtdNSE: LINCOLN · BSE: 531633 | Pharmaceuticals & Biotechnology | ₹1,184 Cr | 5 | Management Change24 Sep 2026 |
| 1535 | Bajaj Healthcare LtdNSE: BAJAJHCARE · BSE: 539872 | Pharmaceuticals & Biotechnology | ₹1,159 Cr | 6 | Annual General Meeting21 Sep 2026 |
| 1557 | Sigachi Industries LtdNSE: SIGACHI · BSE: 543389 | Pharmaceuticals & Biotechnology | ₹1,125 Cr | 10 | Annual General Meeting15 Sep 2026 |
| 1561 | Remus Pharmaceuticals LtdNSE: REMUS | Pharmaceuticals & Biotechnology | ₹1,115 Cr | 9 | Dividend7 Sep 2026 |